Investing Profile

Kazumi Shiosaki

VC
Managing Director at MPM Capital
Photo of Kazumi Shiosaki, Managing Director at MPM Capital
Your Intro Paths to Kazumi Shiosaki

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Kazumi is a member of
UC Berkeley Network
46 CONNECTIONS
MPM BioImpact Network
20 CONNECTIONS
Takeda Oncology Network
13 CONNECTIONS

Find Kazumi Shiosaki on

cb
Current Investing Position
MPM Capital Managing Director
Investments On Record
4
Current Fund Size
$100M

Kazumi Shiosaki is on these Sector & Stage Rankings

Kazumi Shiosaki's Investments On Record (2)

CompanyStageDateRound SizeTotal Raised
Twentyeight-Seven Therapeutics
Series AMay 2019$15M
Series ASep 2018$65M
Series AApr 2016
$80M
Co-investors: Michal Silverberg (Novartis Venture Fund), Henrijette Richter (Sofinnova Partners)
Epizyme
Series BOct 2009$32M
$45M
Co-investors: David Mott (Mott Family Capital), Beth Seidenberg (Kleiner Perkins), Martin Alexander Gershon (Endeavor Venture Funds)

Kazumi Shiosaki's Experience

Managing Director MPM BioImpactPresent
SVP Drug Discovery Millennium Pharmaceuticals (Formerly COR Therapeutics)Present
SVP Drug Discovery Takeda OncologyPresent
Managing Director MPM CapitalPresent
CEO Epizyme2007 - 2010
CEO Primera2004 - 2006
SVP Drug Discovery Millennium Pharmaceuticals1997 - 2001

Kazumi Shiosaki's Education

UC Berkeley PhD Synthetic Chemistry

Founders who looked at Kazumi Shiosaki's profile also looked at these Scouts & Angels

Photo of Charlie Songhurst, Angel

Photo of Christopher Priebe, Angel

Photo of Justin Waldron, Angel

Photo of Brad Holden, Managing Partner